// App-Quantinova.ai

: RIVAROXABAN INDUCED ANAPHYLAXIS, A RARE NON-HEMORRHAGIC ADVERSE EVENT

Researchers

Presenter

  • Omnia Hamid

Principal Investigators

  • Ibrahim Obeidat

  • Mahmood Mubasher

  • Ashraf Omer Ahmed

  • Mohamed Ali

  • Bashir Ali

Medical Centers

  • Hammad medical coroprtaion, Doha, Qatar

Locations

  • Qatar

Companies

  • Hamad Medical Corpor

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Anaphylaxis

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • Diphenhydramine

  • Derma-Pax lotion

  • Hydrocortisone

  • Epinephrine

  • Adrenaclick

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved